XML 46 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Schedule of Stock by Class
Preferred stock authorized, issued and outstanding was as follows:
June 30, 2021December 31, 2020
SeriesShares
Authorized
Shares Issued and OutstandingShares
Authorized
Shares Issued and Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A27,600,000 24,000,000 27,600,000 24,000,000 
5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C (1)— — 1,500,000 500,000 
5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D500,000 500,000 500,000 500,000 
5.625% Non-Cumulative Preferred Stock, Series E32,200 32,200 32,200 32,200 
4.75% Non-Cumulative Preferred Stock, Series F40,000 40,000 40,000 40,000 
3.85% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G1,000,000 1,000,000 1,000,000 1,000,000 
Series A Junior Participating Preferred Stock10,000,000 — 10,000,000 — 
Not designated160,827,800 — 159,327,800 — 
Total200,000,000 25,572,200 200,000,000 26,072,200 
__________________
(1)On May 17, 2021, the outstanding 500,000 shares of MetLife, Inc.’s 5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C (the “Series C preferred stock”) were irrevocably called for redemption, and on June 15, 2021, MetLife, Inc. redeemed and canceled the shares.
Class of Stock [Line Items]  
Class of Treasury Stock [Table Text Block]
MetLife, Inc. announced that its Board of Directors authorized common stock repurchases as follows:
Authorization Remaining at
Announcement DateAuthorization AmountJune 30, 2021
(In millions)
December 11, 2020$3,000 $723 
July 31, 2019$2,000 $— 
Components of Accumulated Other Comprehensive Income (Loss) Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc. was as follows:
Three Months
Ended
June 30, 2021
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Unrealized
Gains (Losses)
on Derivatives
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period
$16,194 $518 $(4,467)$(1,848)$10,397 
Other comprehensive income (loss) (“OCI”) before reclassifications2,099 828 2,934 
Deferred income tax benefit (expense)
(570)(169)(2)(1)(742)
AOCI before reclassifications, net of income tax
17,723 1,177 (4,463)(1,848)12,589 
Amounts reclassified from AOCI
(15)(131)— 17 (129)
Deferred income tax benefit (expense)
27 — (5)25 
Amounts reclassified from AOCI, net of income tax
(12)(104)— 12 (104)
Sale of subsidiary, net of income tax (2)
(176)— — — (176)
Balance, end of period
$17,535 $1,073 $(4,463)$(1,836)$12,309 
Three Months
Ended
June 30, 2020
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Unrealized
Gains (Losses)
on Derivatives
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period
$15,452 $4,917 $(5,627)$(1,985)$12,757 
OCI before reclassifications
8,505 (639)243 — 8,109 
Deferred income tax benefit (expense)
(1,902)142 — (1,758)
AOCI before reclassifications, net of income tax
22,055 4,420 (5,382)(1,985)19,108 
Amounts reclassified from AOCI
(46)(340)— 22 (364)
Deferred income tax benefit (expense)
(2)74 — (5)67 
Amounts reclassified from AOCI, net of income tax
(48)(266)— 17 (297)
Sale of subsidiary, net of income tax(248)— — — (248)
Balance, end of period
$21,759 $4,154 $(5,382)$(1,968)$18,563 
Six Months
Ended
June 30, 2021
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Unrealized
Gains (Losses)
on Derivatives
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period
$22,217 $1,513 $(3,795)$(1,863)$18,072 
OCI before reclassifications
(5,879)(614)(747)(7,236)
Deferred income tax benefit (expense)
1,376 141 (36)(1)1,480 
AOCI before reclassifications, net of income tax
17,714 1,040 (4,578)(1,860)12,316 
Amounts reclassified from AOCI
15 43 — 31 89 
Deferred income tax benefit (expense)
(4)(10)— (7)(21)
Amounts reclassified from AOCI, net of income tax
11 33 — 24 68 
Sale of subsidiaries, net of income tax (2)(190)— 115 — (75)
Balance, end of period
$17,535 $1,073 $(4,463)$(1,836)$12,309 
Six Months
Ended
June 30, 2020
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
Unrealized
Gains (Losses)
on Derivatives
Foreign
Currency
Translation
Adjustments
Defined
Benefit
Plans
Adjustment
Total
(In millions)
Balance, beginning of period
$18,283 $1,698 $(4,927)$(2,002)$13,052 
OCI before reclassifications
4,886 3,048 (431)— 7,503 
Deferred income tax benefit (expense)
(975)(668)(24)— (1,667)
AOCI before reclassifications, net of income tax
22,194 4,078 (5,382)(2,002)18,888 
Amounts reclassified from AOCI
(233)98 — 43 (92)
Deferred income tax benefit (expense)
46 (22)— (9)15 
Amounts reclassified from AOCI, net of income tax
(187)76 — 34 (77)
Sale of subsidiary, net of income tax(248)— — — (248)
Balance, end of period
$21,759 $4,154 $(5,382)$(1,968)$18,563 
__________________
(1)See Note 6 for information on offsets to investments related to policyholder liabilities, DAC, VOBA and DSI.
(2)See Note 3 for information on the Company’s business dispositions.
Reclassification out of Accumulated Other Comprehensive Income (Loss)
Information regarding amounts reclassified out of each component of AOCI was as follows:
Three Months
 Ended
 June 30,
Six Months
Ended
June 30,
2021202020212020
AOCI ComponentsAmounts Reclassified from AOCIConsolidated Statements of
Operations and
Comprehensive Income (Loss)
Locations
(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)
$(6)$51 $(55)$255 Net investment gains (losses)
Net unrealized investment gains (losses)
(4)(9)(10)Net investment income
Net unrealized investment gains (losses)
25 (6)49 (12)Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax
15 46 (15)233 
Income tax (expense) benefit
(3)(46)
Net unrealized investment gains (losses), net of income tax
12 48 (11)187 
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate derivatives
15 27 15 Net investment income
Interest rate derivatives
19 42 48 48 Net investment gains (losses)
Interest rate derivatives
— — Other expenses
Foreign currency exchange rate derivatives
Net investment income
Foreign currency exchange rate derivatives
95 287 (124)(164)Net investment gains (losses)
Foreign currency exchange rate derivativesOther expenses
Gains (losses) on cash flow hedges, before income tax
131 340 (43)(98)
Income tax (expense) benefit
(27)(74)10 22 
Gains (losses) on cash flow hedges, net of income tax
104 266 (33)(76)
Defined benefit plans adjustment: (1)
Amortization of net actuarial gains (losses)
(35)(26)(53)(52)
Amortization of prior service (costs) credit
18 22 
Amortization of defined benefit plan items, before income tax
(17)(22)(31)(43)
Income tax (expense) benefit
Amortization of defined benefit plan items, net of income tax
(12)(17)(24)(34)
Total reclassifications, net of income tax
$104 $297 $(68)$77 
__________________
(1)These AOCI components are included in the computation of net periodic benefit costs. See Note 12.
Preferred Stock  
Class of Stock [Line Items]  
Dividends Declared [Table Text Block]
The per share and aggregate dividends declared for MetLife, Inc.’s preferred stock were as follows:
Three Month Ended June 30,Six Months Ended June 30,
2021202020212020
SeriesPer ShareAggregatePer ShareAggregatePer ShareAggregatePer ShareAggregate
(In million, except per share data)
A$0.256 $$0.253 $$0.506 $12 $0.506 $12 
C$9.606 $26.250 39 $19.085 10 $26.250 39 
D$— — $— — $29.375 15 $29.375 15 
E$351.563 12 $351.563 12 $703.126 23 $703.126 23 
F$296.875 12 $494.792 20 $593.750 24 $494.792 20 
G$— — $— — $19.785 19 $— — 
Total$35 $77 $103 $109